chr19-45002949-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_006509.4(RELB):c.107G>A(p.Gly36Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 151,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G36R) has been classified as Uncertain significance.
Frequency
Consequence
NM_006509.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RELB | NM_006509.4 | c.107G>A | p.Gly36Glu | missense_variant, splice_region_variant | 2/12 | ENST00000221452.13 | |
RELB | NM_001411087.1 | c.107G>A | p.Gly36Glu | missense_variant, splice_region_variant | 2/11 | ||
RELB | XM_005259128.3 | c.107G>A | p.Gly36Glu | missense_variant, splice_region_variant | 2/11 | ||
RELB | XM_047439189.1 | c.-358G>A | splice_region_variant, 5_prime_UTR_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RELB | ENST00000221452.13 | c.107G>A | p.Gly36Glu | missense_variant, splice_region_variant | 2/12 | 1 | NM_006509.4 | P2 | |
RELB | ENST00000505236.2 | c.107G>A | p.Gly36Glu | missense_variant, splice_region_variant | 2/11 | 5 | A2 | ||
RELB | ENST00000509480.5 | c.107G>A | p.Gly36Glu | missense_variant, splice_region_variant, NMD_transcript_variant | 2/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151986Hom.: 0 Cov.: 31
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151986Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74240
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 01, 2022 | This variant has not been reported in the literature in individuals affected with RELB-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 36 of the RELB protein (p.Gly36Glu). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at